XS
ABBV icon

XR Securities’s AbbVie ABBV Stock Holding History

XR Securities’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-7,400
Closed -$1.15M – 337
2023
Q4 		$1.15M Sell
7,400
-100
-1% -$14.6K 0.04% 179
2023
Q3 		$1.12M Sell
7,500
-1,200
-14% -$176K 0.09% 159
2023
Q2 		$1.17M Sell
8,700
-3,800
-30% -$557K 0.06% 143
2023
Q1 		$1.99M Buy
12,500
+6,900
+123% +$1.05M 0.05% 110
2022
Q4 		$905K Buy
+5,600
New +$859K 0.09% 182
2022
Q2 		– Sell
-12,800
Closed -$6K – 366
2022
Q1 		$6K Buy
+12,800
New +$1.86M ﹤0.01% 318
2021
Q3 		– Sell
-15,300
Closed -$56K – 400
2021
Q2 		$56K Buy
15,300
+3,900
+34% +$439K 0.02% 287
2021
Q1 		$57K Sell
11,400
-10,700
-48% -$1.14M ﹤0.01% 334
2020
Q4 		$3K Buy
22,100
+6,200
+39% +$596K ﹤0.01% 415
2020
Q3 		$18K Sell
15,900
-200
-1% -$18.8K ﹤0.01% 230
2020
Q2 		$27K Buy
16,100
+500
+3% +$44K ﹤0.01% 200
2020
Q1 		$130K Sell
15,600
-4,300
-22% -$366K 0.01% 135
2019
Q4 		$51K Sell
19,900
-2,300
-10% -$191K 0.01% 170
2019
Q3 		$113K Sell
22,200
-200
-0.9% -$13.7K 0.02% 140
2019
Q2 		$124K Buy
22,400
+7,800
+53% +$613K 0.02% 158
2019
Q1 		$85K Sell
14,600
-800
-5% -$65.4K 0.01% 178
2018
Q4 		$61K Sell
15,400
-2,900
-16% -$255K 0.03% 194
2018
Q3 		$60K Buy
+18,300
New +$1.74M 0.02% 235

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

XR Securities's ABBV Position: Q2 2023 in Review

XR Securities sold out of AbbVie (ABBV) in Q2 2023, closing a stake of 1,330 shares — an estimated $195K sold.

XR Securities first reported a position in ABBV in Q3 2018 and held it in 10 quarters. The position peaked at $1.28M in Q4 2021. 3,076 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.

  • XR Securities reported no remaining AbbVie position as of Q2 2023 after selling out during the quarter.
  • XR Securities sold 1,330 AbbVie shares in Q2 2023, an estimated $195K.
  • XR Securities first reported a position in AbbVie in Q3 2018 and held it in 10 quarters.
  • XR Securities's AbbVie position peaked at $1.28M in Q4 2021.
  • 3,076 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.

Based on XR Securities's 13F filing for Q2 2023, filed 8 Aug 2023.